TY  - JOUR
AU  - Morales, María Luz
AU  - Arenas, Alicia
AU  - Ortiz-Ruiz, Alejandra
AU  - Leivas, Alejandra
AU  - Rapado, Inmaculada
AU  - Rodríguez-García, Alba
AU  - Castro, Nerea
AU  - Zagorac, Ivana
AU  - Quintela Fandino, Miguel Angel
AU  - Gómez-López, Gonzalo
AU  - Gallardo, Miguel
AU  - Ayala, Rosa
AU  - Linares, María
AU  - Martinez-Lopez, Joaquin
PY  - 2019
DO  - 10.1038/s41598-019-54901-9
SN  - 2045-2322
UR  - http://hdl.handle.net/20.500.12105/9353
AB  - FMS-like tyrosine kinase 3 (FLT3) is a key driver of acute myeloid leukemia (AML). Several tyrosine kinase inhibitors (TKIs) targeting FLT3 have been evaluated clinically, but their effects are limited when used in monotherapy due to the emergence of...
LA  - eng
PB  - Nature Publishing Group
TI  - MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia
TY  - journal article
ER  -